tiprankstipranks
RedHill Biopharma (RDHL)
NASDAQ:RDHL
US Market
RDHL
RedHill Biopharma
RESEARCH TOOLSreports
Want to see RDHL full AI Analyst Report?

RedHill Biopharma (RDHL) Income Statement

874 Followers

RedHill Biopharma Income Statement

Last quarter (Q2 2025), RedHill Biopharma's total revenue was $2.04M, an increase of 58.59% from the same quarter last year. In Q2, RedHill Biopharma's net income was $-2.07M. See RedHill Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 286.00K$ 8.04M$ 6.53M$ 61.80M$ 85.76M
Gross Profit
$ 286.00K$ 4.85M$ 3.07M$ 28.46M$ 36.35M
Operating Expenses
$ 8.20M$ 19.46M$ -9.56M$ 71.31M$ 117.49M
Depreciation and Amortization
$ 409.00K$ 619.00K$ 1.99M$ 8.15M$ 18.15M
EBITDA
$ -7.65M$ -7.59M$ 26.27M$ -22.18M$ -63.03M
Operating Income
$ -7.91M$ -14.61M$ 12.63M$ -42.84M$ -81.14M
Other Income/Expenses
$ -171.00K$ 6.34M$ 11.28M$ -28.82M$ -16.61M
Pretax Income
$ -8.08M$ -8.27M$ 23.92M$ -71.67M$ -97.74M
Net Income
$ -429.00K$ -8.27M$ 23.92M$ -71.67M$ -97.74M
Per Share Metrics
Basic EPS
$ 0.00$ -7.00$ 46.00$ -600.00$ -1.00K
Diluted EPS
$ 0.00$ -7.00$ 46.00$ -600.00$ -1.00K
Weighted Average Shares Outstanding
 0.00 2.46M 518.24K 123.86K 93.05K
Weighted Average Shares Outstanding (Diluted)
 0.00 2.46M 518.24K 123.86K 93.05K
Currency in USD

RedHill Biopharma Earnings and Revenue History